{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:01:39Z","timestamp":1787014899639,"version":"build-2736575974"},"reference-count":98,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1949,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1111\/j.1529-8019.2010.01323.x","type":"journal-article","created":{"date-parts":[[2010,5,23]],"date-time":"2010-05-23T10:58:46Z","timestamp":1274612326000},"page":"268-280","source":"Crossref","is-referenced-by-count":52,"title":["The management of mucous membrane pemphigoid and pemphigus"],"prefix":"10.1155","volume":"23","author":[{"given":"Richelle M.","family":"Knudson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amer N.","family":"Kalaaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison J.","family":"Bruce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","reference":[{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0161-6420(81)35069-6","article-title":"Ocular cicatricial pemphigoid","volume":"88","author":"Mondino","year":"1981","journal-title":"Ophthalmology"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1365-4362.1986.tb04544.x","article-title":"Cicatricial pemphigoid","volume":"25","author":"Ahmed","year":"1986","journal-title":"Int J Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/0030-4220(82)90080-9","article-title":"Bullous pemphigoid, cicatricial pemphigoid and pemphigus vulgaris: a comparative clinical survey of 278 cases","volume":"54","author":"Laskaris","year":"1982","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1365-2230.1977.tb02570.x","article-title":"Cicatricial pemphigoid in a young girl","volume":"2","author":"Jolliffe","year":"1977","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1440-0960.1981.tb00773.x","article-title":"Cicatricial pemphigoid in a 4-year-old child","volume":"22","author":"Rogers","year":"1981","journal-title":"Australas J Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1001\/archderm.138.3.370","article-title":"The first international consensus on mucous membrane pemphigoid","volume":"138","author":"Chan","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1067\/mjd.2000.107248","article-title":"Cicatricial pemphigoid","volume":"43","author":"Fleming","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0140-6736(05)66829-8","article-title":"Pemphigus","volume":"366","author":"Bystryn","year":"2005","journal-title":"Lancet"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1001\/archderm.1996.03890260105016","article-title":"The adjuvant therapy of pemphigus. An update","volume":"132","author":"Bystryn","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1111\/j.0022-202X.2004.23930.x","article-title":"IVIg treatment of pemphigus: how it works and how to use it","volume":"125","author":"Bystryn","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0190-9622(00)90213-5","article-title":"Patterns of remission in pemphigus vulgaris","volume":"42","author":"Herbst","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/j.1346-8138.1994.tb01811.x","article-title":"Factors responsible for death in patients with pemphigus","volume":"21","author":"Kanwar","year":"1994","journal-title":"J Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0738-081X(00)00190-5","article-title":"Therapy of pemphigus","volume":"19","author":"Toth","year":"2001","journal-title":"Clin Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1067\/mjd.2001.114746","article-title":"Treatment of cicatricial pemphigoid with mycophenolate mofetil as a steroid-sparing agent","volume":"45","author":"Megahed","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ophtha.2007.04.027","article-title":"Immunosuppressive therapy for ocular mucous membrane pemphigoid: strategies and outcomes","volume":"115","author":"Saw","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB16|cit16","first-page":"1","article-title":"Update on the use of cyclophosphamide in the management of pemphigus, bullous pemphigoid and cicatricial pemphigoid","volume":"5","author":"Korman","year":"1998","journal-title":"Med Surg Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB17|cit17","first-page":"201","article-title":"Dapsone therapy of cicatricial pemphigoid","volume":"7","author":"Rogers","year":"1988","journal-title":"Semin Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.ophtha.2003.07.010","article-title":"Methotrexate therapy for ocular cicatricial pemphigoid","volume":"111","author":"McCluskey","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0190-9622(87)70069-3","article-title":"Azathioprine in the treatment of pemphigus vulgaris: a long-term follow-up","volume":"16","author":"Aberer","year":"1987","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0190-9622(84)80193-0","article-title":"Cyclophosphamide","volume":"11","author":"Ahmed","year":"1984","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1046\/j.1365-2133.1999.03177.x","article-title":"Mycophenolate mofetil monotherapy for pemphigus vulgaris","volume":"141","author":"Bredlich","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1001\/archderm.135.1.54","article-title":"Mycophenolate is effective in the treatment of pemphigus vulgaris","volume":"135","author":"Enk","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1001\/archderm.1978.01640180023005","article-title":"Successful treatment of cyclophosphamide and prednisolone for initial treatment of pemphigus vulgaris","volume":"114","author":"Fellner","year":"1978","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1001\/archderm.135.6.724","article-title":"Treatment of pemphigus vulgaris and bullous pemphigoid with mycophenolate mofetil monotherapy","volume":"135","author":"Grundmann-Kollmann","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1001\/archderm.136.7.868","article-title":"Ineffectiveness of cyclosporine as an adjuvant to corticosteroids in the treatment of pemphigus","volume":"136","author":"Ioannides","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1001\/archderm.1971.04000190016003","article-title":"Pemphigus. A 20-year survey of experience with 70 cases","volume":"104","author":"Ryan","year":"1971","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1001\/archderm.1972.01620140005001","article-title":"Cyclophosphamide in the treatment of pemphigus vulgaris and bullous pemphigoid","volume":"106","author":"Krain","year":"1972","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0190-9622(03)02738-5","article-title":"Differences and similarities among expert opinions on the diagnosis and treatment of pemphigus vulgaris","volume":"49","author":"Mimouni","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1365-2133.1975.tb02251.x","article-title":"Treatment of pemphigus with cyclophosphamide","volume":"93","author":"Pasricha","year":"1975","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1001\/archderm.135.10.1275","article-title":"Methotrexate as an adjuvant treatment for pemphigus vulgaris","volume":"135","author":"Smith","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1346-8138.1979.tb01927.x","article-title":"Treatment of pemphigus with corticosteroids and cyclophosphamide","volume":"6","author":"Piamphongsant","year":"1979","journal-title":"J Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1001\/archderm.144.1.25","article-title":"Multicenter randomized, double-blind, placebo-controlled, clinical trial of dapsone as a glucocorticoid-sparing agent in maintenance-phase pemphigus vulgaris","volume":"144","author":"Werth","year":"2008","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1365-2230.1995.tb01317.x","article-title":"Treatment of cicatricial pemphigoid with tetracycline and nicotinamide","volume":"20","author":"Poskitt","year":"1995","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1046\/j.1365-2230.1998.00379.x","article-title":"Combination therapy with nicotinamide and tetracycline for cicatricial pemphigoid: further support for its efficacy","volume":"23","author":"Reiche","year":"1998","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1001\/archderm.134.9.1104","article-title":"Treatment of pemphigus with gold","volume":"134","author":"Pandya","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/archderm.1973.01620220028007","article-title":"Gold sodium thiomalate treatment of pemphigus","volume":"108","author":"Penneys","year":"1973","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1001\/archderm.1976.01630260013004","article-title":"Management of pemphigus with gold compounds. A long-term follow-up report","volume":"112","author":"Penneys","year":"1976","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1468-3083.1995.tb00109.x","article-title":"Intramuscular gold therapy for young patients with pemphigus vulgaris: a prospective, open, clinical study utilizing a dermatologist\/rheumatologist team approach","volume":"5","author":"Sutej","year":"1995","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1001\/archderm.137.9.1181","article-title":"Comparison between IVIG and conventional immunosuppressive therapy regimens in patients with severe oral pemphigoid","volume":"137","author":"Ahmed","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1001\/archderm.139.8.1051","article-title":"Consensus statement on the use of intravenous immunoglobulin therapy in the treatment of autoimmune mucocutaneous blistering diseases","volume":"139","author":"Ahmed","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jaad.2008.09.052","article-title":"A randomized double-blind trial of intravenous immunoglobulin for pemphigus","volume":"60","author":"Amagai","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/j.1468-3083.2006.01540.x","article-title":"The role of IVIg treatment in severe pemphigus vulgaris","volume":"20","author":"Baum","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1067\/mjd.2002.122735","article-title":"Treatment of pemphigus with intravenous immunoglobulin","volume":"47","author":"Bystryn","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1016\/S0161-6420(99)90496-7","article-title":"IVIG therapy for ocular cicatricial pemphigoid: a preliminary study","volume":"106","author":"Ahmed","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1001\/archderm.134.1.80","article-title":"Dermatological uses of high-dose intravenous immunoglobulin","volume":"134","author":"Jolles","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB46|cit46","first-page":"119","article-title":"Intravenous immunoglobulins in the therapy of autoimmune and systemic inflammatory disorders","volume":"74","author":"Mobini","year":"1995","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB47|cit47","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1006\/clim.2001.5150","article-title":"IVIG therapy in patients with multiple mucosal involvement in mucous membrane pemphigoid","volume":"102","author":"Sami","year":"2002","journal-title":"Clin Immunol"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB48|cit48","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1046\/j.1365-2249.2002.01942.x","article-title":"Treatment of oral pemphigoid with IVIG as monotherapy long-term follow-up: influence of treatment on autoantibody titers to human alpha 6 integrin","volume":"129","author":"Sami","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB49|cit49","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.jaad.2006.06.029","article-title":"High-dose intravenous immunoglobulins for the treatment of autoimmune mucocutaneous blistering diseases: evaluation of its use in 19 cases","volume":"56","author":"Segura","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB50|cit50","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1001\/archderm.1988.01670110019004","article-title":"Controlled study of plasma exchange in pemphigus","volume":"124","author":"Guillaume","year":"1988","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB51|cit51","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/j.1365-2133.2003.05665.x","article-title":"Guidelines for the management of pemphigus vulgaris","volume":"149","author":"Harman","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB52|cit52","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000018433","article-title":"A case of antiepiligrin cicatricial pemphigoid successfully treated by plasmapheresis","volume":"201","author":"Hashimoto","year":"2000","journal-title":"Dermatology"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB53|cit53","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1001\/archderm.1997.03890390021002","article-title":"Severe pemphigus foliaceus treated with extracorporeal photochemotherapy","volume":"133","author":"Azana","year":"1997","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB54|cit54","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0190-9622(08)80854-7","article-title":"Unresponsive severe generalized pemphigus vulgaris successfully controlled by extracorporeal photophoresis","volume":"28","author":"Gollnick","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB55|cit55","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0190-9622(08)80560-9","article-title":"Pemphigus vulgaris treated with photopheresis","volume":"26","author":"Liang","year":"1992","journal-title":"J of the Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB56|cit56","first-page":"647","article-title":"Treatment of autoimmune disease with extracorporeal photochemotherapy: pemphigus vulgaris: preliminary report","volume":"62","author":"Rook","year":"1989","journal-title":"Yale J Biol Med"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB57|cit57","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1159\/000018090","article-title":"Short-time extracorporeal photochemotherapy in the treatment of drug-resistant autoimmune bullous diseases","volume":"198","author":"Wollina","year":"1999","journal-title":"Dermatology"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB58|cit58","first-page":"266","article-title":"Delayed response of oral pemphigus vulgaris to rituximab treatment","volume":"16","author":"Niedermeier","year":"2006","journal-title":"Eur J Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB59|cit59","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1136\/bjo.2007.129510","article-title":"The use of rituximab in refractory mucous membrane pemphigoid with severe ocular involvement","volume":"93","author":"Ross","year":"2009","journal-title":"Br J Ophthalmol"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB60|cit60","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1749-6632.2009.04744.x","article-title":"Rituximab in severe pemphigus","volume":"1173","author":"Schmidt","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB61|cit61","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2340\/00015555-0560","article-title":"Successful treatment of mucous membrane pemphigoid with the anti-CD20 antibody rituximab","volume":"89","author":"Schumann","year":"2009","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB62|cit62","first-page":"731","article-title":"Successful adjuvant treatment of recalcitrant mucous membrane pemphigoid with anti-CD20 antibody rituximab","volume":"6","author":"Taverna","year":"2007","journal-title":"J Drugs Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB63|cit63","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1001\/archderm.142.11.1457","article-title":"Successful treatment of mucous membrane pemphigoid with etanercept in 3 patients","volume":"142","author":"Canizares","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB64|cit64","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1067\/mjd.2001.119100","article-title":"Treatment of recalcitrant cicatricial pemphigoid with the tumor necrosis factor alpha antagonist etanercept","volume":"46","author":"Sacher","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB65|cit65","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/archderm.142.10.1268","article-title":"Successful treatment of mucous membrane pemphigoid with infliximab","volume":"142","author":"Hefferman","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB66|cit66","doi-asserted-by":"crossref","first-page":"S193","DOI":"10.1067\/mjd.2002.109255","article-title":"Thalidomide therapy for cicatricial pemphigoid","volume":"47","author":"Duong","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB67|cit67","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0161-6420(99)90022-2","article-title":"Subconjunctival mitomycin C for the treatment of ocular cicatricial pemphigoid","volume":"106","author":"Donnenfelt","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB68|cit68","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/0190-9622(91)70159-Y","article-title":"Cicatricial pemphigoid","volume":"24","author":"Ahmed","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB69|cit69","first-page":"105","article-title":"Management of oral manifestations of mucous membrane pemphigoid","volume":"2","author":"Muzyka","year":"1994","journal-title":"J Geriatr Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB70|cit70","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0030-4220(91)90300-2","article-title":"Open preliminary clinical trial of clobetasol propionate ointment in adhesive paste for treatment of chronic oral vesiculo-erosive diseases","volume":"71","author":"Lozada-Nur","year":"1991","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB71|cit71","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1001\/archderm.1991.04510010047004","article-title":"Oral insertable prosthetic device as an aid in treating oral ulcers","volume":"127","author":"Lee","year":"1991","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB72|cit72","first-page":"527","article-title":"Cicatricial pemphigoid","volume":"85","author":"Foster","year":"1986","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB73|cit73","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/j.1365-2230.2004.01619.x","article-title":"Topical tacrolimus for oral cicatricial pemphigoid","volume":"29","author":"Assman","year":"2004","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB74|cit74","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0190-9622(03)01830-9","article-title":"Topical tacrolimus treatment for cicatricial pemphigoid","volume":"50","author":"Gunther","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB75|cit75","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1001\/archderm.139.8.1083","article-title":"Ocular mucous membrane pemphigoid and ocular pemphigus vulgaris treated topically with tacrolimus ointment","volume":"139","author":"Hall","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB76|cit76","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1159\/000077319","article-title":"Localized childhood vulval pemphigoid treated with tacrolimus ointment","volume":"208","author":"Lebeau","year":"2004","journal-title":"Dermatology"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB77|cit77","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/0030-4220(93)90012-S","article-title":"Clinical, historic, and therapeutic features of cicatricial pemphigoid","volume":"76","author":"Vincent","year":"1993","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB78|cit78","first-page":"2","article-title":"Prevention and treatment of glucocorticoid-induced osteoporosis in dermatologic practice: a review","volume":"7","author":"Khan","year":"2008","journal-title":"J Drugs Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB79|cit79","article-title":"Development of Pneumocystis carinii pneumonia in patients with immunobullous and connective tissue disease receiving immunosuppressive medications","author":"Gerhart","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB80|cit80","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0140-6736(77)92065-7","article-title":"The big shot","volume":"309","year":"1977","journal-title":"Lancet"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB81|cit81","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1001\/archderm.142.5.570","article-title":"Randomized controlled trial of adjuvant oral dexamethasone pulse therapy in pemphigus vulgaris","volume":"142","author":"Mentink","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB82|cit82","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1001\/jama.1993.03500160080036","article-title":"Side effects of glucocorticoid treatment: experience of the optic neuritis treatment trial","volume":"269","author":"Chrousos","year":"1993","journal-title":"JAMA"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB83|cit83","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1001\/archderm.1990.01670310081011","article-title":"The incidence of agranulocytosis during treatment of dermatitis herpetiformis with dapsone as reported in Sweden, 1972 through 1988","volume":"126","author":"Hornsten","year":"1990","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB84|cit84","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1016\/S0161-6420(94)31098-0","article-title":"Dapsone-induced neutropenia in patients treated for ocular cicatricial pemphigoid","volume":"101","author":"Raizman","year":"1994","journal-title":"Ophthalmology"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB85|cit85","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0190-9622(96)80066-1","article-title":"Influence of treatment on the clinical course of pemphigus vulgaris","volume":"34","author":"Carson","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB86|cit86","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0926-9959(94)00098-K","article-title":"Early treatment of pemphigus does not improve the prognosis: a review of 53 patients","volume":"4","author":"Wolf","year":"1995","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB87|cit87","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1001\/archderm.1973.01620180007002","article-title":"Pemphigus treatment with azathioprine","volume":"107","author":"Roenigk","year":"1973","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB88|cit88","first-page":"853","article-title":"The role of mycophenolate mofetil in the management of pemphigus","volume":"135","author":"Nousari","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB89|cit89","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2165\/00128071-200405050-00005","article-title":"Management of bullous pemphigoid: recommendations for immunomodulatory treatments","volume":"5","author":"Kirtschig","year":"2004","journal-title":"Am J Clin Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB90|cit90","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1001\/archderm.142.11.1447","article-title":"A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of pemphigus","volume":"142","author":"Beissert","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB91|cit91","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1067\/mjd.2001.112325","article-title":"High-dose intravenous immunoglobulins: an approach to treat severe immune-mediated and autoimmune diseases of the skin","volume":"44","author":"Rutter","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB92|cit92","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1046\/j.1365-2133.1998.02169.x","article-title":"Cytokine pattern in blister fluid and serum of patients with bullous pemphigoid: relationships with disease intensity","volume":"138","author":"Ameglio","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB93|cit93","first-page":"3522","article-title":"Serum levels of tumor necrosis factor alpha and interleukin-6 in ocular cicatricial pemphigoid","volume":"34","author":"Lee","year":"1993","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB94|cit94","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nrd2085","article-title":"B cells move to centre stage: novel opportunities for autoimmune disease treatment","volume":"5","author":"Browning","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB95|cit95","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1001\/archderm.136.2.174","article-title":"Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid","volume":"136","author":"Schmidt","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB96|cit96","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1001\/jama.1965.03080210026006","article-title":"Autoantibodies in pemphigus vulgaris. Response to an intercellular substance of epidermis","volume":"92","author":"Beutner","year":"1965","journal-title":"JAMA"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB97|cit97","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3181\/00379727-117-29622","article-title":"Demonstration of skin antibodies in serum of pemphigus vulgaris patients by indirect immunofluorescence staining","volume":"117","author":"Beutner","year":"1964","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1111\/j.1529-8019.2010.01323.x-BIB98|cit98","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.4049\/jimmunol.159.4.2010","article-title":"Characterization of autoantibodies in pemphigus using antigen-specific enzyme-linked immunosorbent assays with baculovirus-expressed recombinant desmogleins","volume":"159","author":"Ishii","year":"1997","journal-title":"J Immunol"}],"container-title":["Dermatologic Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1529-8019.2010.01323.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1529-8019.2010.01323.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T03:48:08Z","timestamp":1685591288000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1529-8019.2010.01323.x"}},"subtitle":["Mucous membrane pemphigoid and pemphigus"],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":98,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.1111\/j.1529-8019.2010.01323.x","relation":{},"ISSN":["1396-0296","1529-8019"],"issn-type":[{"value":"1396-0296","type":"print"},{"value":"1529-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5]]}}}